Late Breakers
Top 5 Industry Updates
Romosozumab Improves Bone Mineral Density of the Lumbar Spine in Patients Receiving Glucocorticoids
Could Diet Be Fueling the AD Epidemic? A Nationwide Analysis Points to Inflammatory Eating Patterns
A large-scale Korean study links pro-inflammatory diets to higher atopic dermatitis prevalence, especially among women and younger individuals.
Industry Information
New Data Show 40-Gene Expression Profile (DecisionDx®-SCC) Identifies Cutaneous Squamous Cell Carcinoma Patients Most Likely to Benefit from Adjuvant Radiation Therapy
Study results demonstrate that DecisionDx-SCC can identify high-risk cutaneous squamous cell carcinoma patients who are most likely to benefit from adjuvant radiation therapy.
Non-targeted Screening Superior to Targeted Screening for Identifying New HCV Infections
A new study reveals that using a non-targeted screening approach in the emergency department may identify more hepatitis C virus infections.
Ketamine, Dexmedetomidine Comparable in Reducing Inflammation, Pain After Liver Resection
A new study found no obvious superiority in the effects of ketamine versus dexmedetomidine after liver resection.
Delgocitinib Cream FDA Approved as First Treatment for Chronic Hand Eczema
ANZUPGO® (delgocitinib) cream is the first FDA-approved topical treatment for moderate-to-severe chronic hand eczema (CHE) in adults.
